Zoetis (ZTS) Stock Forecast & Price Target

Compare

3,744 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ZTS Analyst Ratings

Moderate Buy

8 Buy

3 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Zoetis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ZTS Stock 12 Month Forecast

Average Price Target

$187.40

▲(32.80% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is $187.40 with a high forecast of $221.00 and a low forecast of $153.00. The average price target represents a 32.80% change from the last price of $141.11.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"145":"$145","222":"$222","164.25":"$164.3","183.5":"$183.5","202.75":"$202.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":221,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$221.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":187.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$187.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":153,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$153.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[145,164.25,183.5,202.75,222],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,146.95,152.64615384615382,158.34230769230768,164.03846153846152,169.73461538461538,175.43076923076922,181.12692307692308,186.8230769230769,192.51923076923077,198.2153846153846,203.91153846153847,209.6076923076923,215.30384615384617,{"y":221,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,146.95,150.06153846153845,153.1730769230769,156.2846153846154,159.39615384615385,162.5076923076923,165.61923076923077,168.73076923076923,171.84230769230768,174.95384615384614,178.06538461538463,181.1769230769231,184.28846153846155,{"y":187.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,146.95,147.4153846153846,147.88076923076923,148.34615384615384,148.81153846153845,149.27692307692308,149.7423076923077,150.2076923076923,150.6730769230769,151.13846153846154,151.60384615384615,152.06923076923076,152.5346153846154,{"y":153,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":192.08,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":180.19,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.1,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.35,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.76,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.83,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.13,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.86,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.66,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.95,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$221.00

Average Price Target$187.40

Lowest Price Target$153.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Daniel Clark

Leerink Partners

$153→$152

Hold

7.72%

Upside

Reiterated

10/13/25

Leerink Partners Sticks to Their Hold Rating for Zoetis (ZTS)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

10/13/25

Buy Rating on Zoetis: Strategic Initiatives and Long-term Growth Potential Amid Short-term Challenges

Michael Ryskin

Bank of America Securities

$200

Buy

41.73%

Upside

Reiterated

10/10/25

Zoetis's Strategic Launch of Innovative Monoclonal Antibodies for Osteoarthritic Pain ManagementWe believe all of these factors will lead to a positive contribution over time, as the pain mAb market is a large unmet need (esp. w/ a long-acting solution). However, initial contribution in 2026 is likely to be modest, especially considering what we anticipate will be sizeable cannibalization of existing Librela / Solensia sales. At the very least, these pending approvals/launches could start to change the narrative and sentiment on ZTS, which has been markedly negative in light of the Librela challenges and pending competition from ELAN/MRK (Elanco Animal Health/Merck) launches. We maintain our Buy rating on ZTS and look forward to further updates on the mAb portfolio and other pipeline products in the coming 3Q earnings call.

Unknown Analyst

Argus Research

Not Ranked

Argus Research

$190

Buy

34.65%

Upside

Reiterated

09/09/25

Argus Research Sticks to Its Buy Rating for Zoetis (ZTS)

Jonathan Block

Stifel Nicolaus

$155

Hold

9.84%

Upside

Reiterated

09/03/25

Stifel Nicolaus Reaffirms Their Hold Rating on Zoetis (ZTS)

Bryce Generon

TR | OpenAI - 4o

$174→$173

Buy

22.60%

Upside

Reiterated

09/03/25

AI Generated ArticleAI Generated Article

Mark Massaro

BTIG

$200

Buy

41.73%

Upside

Reiterated

08/21/25

Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)We reiterate our Buy rating and $200 PT on shares of ZTS.

David Westenberg

Piper Sandler

$210→$215

Buy

52.36%

Upside

Reiterated

08/11/25

Piper Sandler Keeps Their Buy Rating on Zoetis (ZTS)

Andrea Alfonso

UBS

$170→$165

Hold

16.93%

Upside

Reiterated

08/06/25

UBS Sticks to Its Hold Rating for Zoetis (ZTS)

Steve Scala

TD Cowen

$202

Buy

43.15%

Upside

Assigned

08/05/25

TD Cowen Reaffirms Their Buy Rating on Zoetis (ZTS)

Erin Wright

Morgan Stanley

$238→$221

Buy

56.62%

Upside

Reiterated

07/29/25

Morgan Stanley Remains a Buy on Zoetis (ZTS)Morgan Stanley analyst Erin Wright lowered the price target on Zoetis Inc. (NYSE: ZTS) to $221.00 (from $238.00) while maintaining a Overweight rating.

Sidharth Sahoo

HSBC

$225→$180

Buy

27.56%

Upside

Reiterated

04/28/25

Zoetis price target lowered to $180 from $225 at HSBCZoetis price target lowered to $180 from $225 at HSBC

Balaji Prasad

Barclays

$242

Buy

71.50%

Upside

Reiterated

02/12/25

Barclays Sticks to Their Buy Rating for Zoetis (ZTS)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Daniel Clark

Leerink Partners

$153→$152

Hold

7.72%

Upside

Reiterated

10/13/25

Leerink Partners Sticks to Their Hold Rating for Zoetis (ZTS)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

10/13/25

Buy Rating on Zoetis: Strategic Initiatives and Long-term Growth Potential Amid Short-term Challenges

Michael Ryskin

Bank of America Securities

$200

Buy

41.73%

Upside

Reiterated

10/10/25

Unknown Analyst

Argus Research

Not Ranked

Argus Research

$190

Buy

34.65%

Upside

Reiterated

09/09/25

Argus Research Sticks to Its Buy Rating for Zoetis (ZTS)

Jonathan Block

Stifel Nicolaus

$155

Hold

9.84%

Upside

Reiterated

09/03/25

Stifel Nicolaus Reaffirms Their Hold Rating on Zoetis (ZTS)

Bryce Generon

TR | OpenAI - 4o

$174→$173

Buy

22.60%

Upside

Reiterated

09/03/25

AI Generated ArticleAI Generated Article

Mark Massaro

BTIG

$200

Buy

41.73%

Upside

Reiterated

08/21/25

Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)We reiterate our Buy rating and $200 PT on shares of ZTS.

David Westenberg

Piper Sandler

$210→$215

Buy

52.36%

Upside

Reiterated

08/11/25

Piper Sandler Keeps Their Buy Rating on Zoetis (ZTS)

Andrea Alfonso

UBS

$170→$165

Hold

16.93%

Upside

Reiterated

08/06/25

UBS Sticks to Its Hold Rating for Zoetis (ZTS)

Steve Scala

TD Cowen

$202

Buy

43.15%

Upside

Assigned

08/05/25

TD Cowen Reaffirms Their Buy Rating on Zoetis (ZTS)

Erin Wright

Morgan Stanley

$238→$221

Buy

56.62%

Upside

Reiterated

07/29/25

Morgan Stanley Remains a Buy on Zoetis (ZTS)Morgan Stanley analyst Erin Wright lowered the price target on Zoetis Inc. (NYSE: ZTS) to $221.00 (from $238.00) while maintaining a Overweight rating.

Sidharth Sahoo

HSBC

$225→$180

Buy

27.56%

Upside

Reiterated

04/28/25

Zoetis price target lowered to $180 from $225 at HSBCZoetis price target lowered to $180 from $225 at HSBC

Balaji Prasad

Barclays

$242

Buy

71.50%

Upside

Reiterated

02/12/25

Barclays Sticks to Their Buy Rating for Zoetis (ZTS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zoetis

1 Month

xxx

Success Rate

14/24 ratings generated profit

Average Return

+2.15%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +2.15% per trade.

3 Months

xxx

Success Rate

14/24 ratings generated profit

Average Return

+4.23%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +4.23% per trade.

1 Year

Erin WrightMorgan Stanley

Success Rate

16/24 ratings generated profit

Average Return

+13.27%

reiterated a buy rating 3 months ago

Copying Erin Wright's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +13.27% per trade.

2 Years

xxx

Success Rate

15/24 ratings generated profit

Average Return

+35.28%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +35.28% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZTS Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ZTS has received 13 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. ZTS average Analyst price target in the past 3 months is 187.40.

Each month's total comprises the sum of three months' worth of ratings.

ZTS Financial Forecast

ZTS Earnings Forecast

Next quarter’s earnings estimate for ZTS is $1.62 with a range of $1.57 to $1.66. The previous quarter’s EPS was $1.76. ZTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year ZTS has Preformed in-line its overall industry.

ZTS Sales Forecast

Next quarter’s sales forecast for ZTS is $2.41B with a range of $2.38B to $2.43B. The previous quarter’s sales results were $2.46B. ZTS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ZTS has Preformed in-line its overall industry.

ZTS Stock Forecast FAQ

What is ZTS’s average 12-month price target, according to analysts?

Based on analyst ratings, Zoetis’s 12-month average price target is 187.40.

What is ZTS’s upside potential, based on the analysts’ average price target?

Zoetis has 32.80% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ZTS a Buy, Sell or Hold?

Zoetis has a consensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 0 sell ratings.

What is Zoetis’s price target?

The average price target for Zoetis is 187.40. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $221.00 ,the lowest forecast is $153.00. The average price target represents 32.80% Increase from the current price of $141.11.

What do analysts say about Zoetis?

Zoetis’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of ZTS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Zoetis (ZTS) Stock Forecast & Price Target

ZTS Analyst Ratings

ZTS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zoetis

ZTS Analyst Recommendation Trends

ZTS Financial Forecast

ZTS Earnings Forecast

ZTS Sales Forecast

ZTS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts